Gene Dosage of 9p21 Affects Risk, Severity of Coronary Artery Disease | GenomeWeb

The 9p21 variant has been well linked to heart disease, but researchers are only beginning to untangle how that connection works. In 2007, a group led by the University of Texas Southwestern Medical Center's Jonathan Cohen reported in Science that people who are homozygous for the 9p21 variant — which is common in Asian and Caucasian populations — had a 30 to 40 percent increased risk of developing coronary artery disease than people without the variant.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.